A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts

For physiologically important cancer therapeutic targets, use of non-invasive imaging for therapeutic guidance and monitoring may improve outcomes for treated patients. The CXC chemokine receptor 4 (CXCR4) is overexpressed in many cancers including non-small cell lung cancer (NSCLC) and triple negat...

Descripción completa

Detalles Bibliográficos
Autores principales: Azad, Babak Behnam, Chatterjee, Samit, Lesniak, Wojciech G., Lisok, Ala, Pullambhatla, Mrudula, Bhujwalla, Zaver M., Pomper, Martin G., Nimmagadda, Sridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914289/
https://www.ncbi.nlm.nih.gov/pubmed/26848769
http://dx.doi.org/10.18632/oncotarget.7111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914289/
https://www.ncbi.nlm.nih.gov/pubmed/26848769
http://dx.doi.org/10.18632/oncotarget.7111

Ejemplares similares